CompuMed, Inc.
CMPD
$3.00
-$0.80-21.05%
03/31/2012 | |||||
---|---|---|---|---|---|
Revenue | 6.17% | ||||
Total Other Revenue | -- | ||||
Total Revenue | 6.17% | ||||
Cost of Revenue | 5.42% | ||||
Gross Profit | 6.93% | ||||
SG&A Expenses | 26.70% | ||||
Depreciation & Amortization | -10.53% | ||||
Other Operating Expenses | -- | ||||
Total Operating Expenses | 14.53% | ||||
Operating Income | -437.50% | ||||
Income Before Tax | -276.92% | ||||
Income Tax Expenses | -- | ||||
Earnings from Continuing Operations | -276.92% | ||||
Earnings from Discontinued Operations | -- | ||||
Extraordinary Item & Accounting Change | -- | ||||
Minority Interest in Earnings | -- | ||||
Net Income | -276.92% | ||||
EBIT | -437.50% | ||||
EBITDA | -336.36% | ||||
EPS Basic | -15.00% | ||||
Normalized Basic EPS | -276.71% | ||||
EPS Diluted | -15.00% | ||||
Normalized Diluted EPS | -276.71% | ||||
Average Basic Shares Outstanding | 0.00% | ||||
Average Diluted Shares Outstanding | 0.00% | ||||
Dividend Per Share | -- | ||||
Payout Ratio | -- |